MicroRNA-149 inhibits the progression of lung adenocarcinoma through targeting RAP1B and inactivating Wnt/ β-catenin pathway.

CONCLUSIONS: MiR-149 inhibited the progression of LAD by restraining RAP1B/EMT and inactivating Wnt/β-catenin pathway. PMID: 32432747 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32432747?dopt=Abstract

Source: European Review for Medical and Pharmacological Sciences - May 22, 2020 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research